분변 면역화학 진단 검사(FIT) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Fecal Immunochemical Diagnostic Test (FIT) Market (Product: Kits & Reagents, Analyzers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

US $ 5,795 ￦ 8,407,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795 ￦ 12,760,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795 ￦ 17,113,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

분변 면역화학 진단 검사(FIT) 시장 - 보고서의 범위

TMR의 세계 분변 면역화학 진단 검사(FIT) 시장에 대한 조사 보고서는 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회도 조사했습니다. 예측 연도로서 2017년부터 2031년까지 세계 시장 수익을 제공합니다. 또한 2023-2031년간 세계 시장의 복합 연간 성장률(CAGR%)도 제시합니다.

이 보고서는 광범위한 조사를 통해 작성되었으며, 1차 조사에서는 분석가들이 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하여 주요 조사 활동의 대부분을 수행했으며, 2차 조사에서는 주요 기업의 제품 문헌, 연례 보고서, 보도 자료 및 관련 문서에 대한 참조를 통해 분변 면역화학 진단 검사(FIT) 시장을 파악했습니다.

이 보고서는 세계의 분변 면역화학 진단 검사(FIT) 시장 경쟁 구도를 자세히 분석합니다. 세계 분변 면역화학 진단 검사(FIT) 시장에서 활동하는 주요 기업이 확인되며, 이들은 다양한 속성 측면에서 프로파일링됩니다. 기업 개요, 재무 상태, 최근 동향, SWOT는 이 보고서에 소개된 세계 분변 면역화학 진단 검사(FIT) 시장 기업의 속성입니다.

목차

제1장 서문

제2장 가정과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

• 서론
• 개요
• 시장 역학
• 세계 시장 분석과 예측, 2017-2031년

제5장 주요 인사이트

• 세계 주요 국가의 질병 유병률과 이환율
• 규제 시나리오
• 가격 분석
• COVID-19 팬데믹이 업계에 미치는 영향

제6장 세계 시장 분석과 예측 : 제품 유형별

• 서론과 정의
• 주요 조사 결과/개발
• 시장 매출 예측 : 제품 유형별, 2017-2031
  • 키트 및 시약
  • 애널라이저
  • 기타
• 시장 매력 분석 : 제품 유형별

제7장 세계 시장 분석과 예측 : 최종사용자별

• 서론과 정의
• 주요 조사 결과/개발
• 시장 매출 예측 : 최종사용자별, 2017-2031
  • 병원 및 진단 실험실
  • 전문 클리닉
  • 가정 치료 환경
  • 조사기관
• 시장 매력 분석 : 최종사용자별

제8장 세계 시장 분석과 예측 : 지역별

• 주요 조사 결과
• 시장 매출 예측 : 지역별
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• 시장 매력 분석 : 지역별

제9장 북미 시장 분석과 예측

제10장 유럽 시장 분석과 예측

제11장 아시아태평양 시장 분석과 예측

제12장 라틴아메리카 시장 분석과 예측

제13장 중동 및 아프리카 시장 분석과 예측

제14장 경쟁 구도

• 시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
• 시장 점유율 분석 : 기업별, 2022년
• 기업 개요
  • Quest Diagnostics Incorporated
  • Sentinel CH. SpA
  • FUJIFILM Corporation
  • Quidel Corporation
  • Danaher(Beckman Coulter, Inc.)
  • Eiken Chemical Co., Ltd.
  • Freenome Holdings, Inc.
  • Immunostics, Inc.
  • BTNX, Inc.
  • Biohit Oyj

LSH

영문 목차

영문목차

Fecal Immunochemical Diagnostic Test (FIT) Market - Scope of Report

TMR's report on the global Fecal Immunochemical Diagnostic Test (FIT) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Fecal Immunochemical Diagnostic Test (FIT) market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Fecal Immunochemical Diagnostic Test (FIT) market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Fecal Immunochemical Diagnostic Test (FIT) market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Fecal Immunochemical Diagnostic Test (FIT) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Fecal Immunochemical Diagnostic Test (FIT) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Fecal Immunochemical Diagnostic Test (FIT) market.

The report delves into the competitive landscape of the global Fecal Immunochemical Diagnostic Test (FIT) market. Key players operating in the global Fecal Immunochemical Diagnostic Test (FIT) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Fecal Immunochemical Diagnostic Test (FIT) market profiled in this report.

Key Questions Answered in Global Fecal Immunochemical Diagnostic Test (FIT) Market Report:

• What is the sales/revenue generated by Fecal Immunochemical Diagnostic Test (FIT) across all regions during the forecast period?
• What are the opportunities in the global Fecal Immunochemical Diagnostic Test (FIT) market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Fecal Immunochemical Diagnostic Test (FIT) Market - Research Objectives and Research Approach

The comprehensive report on the global Fecal Immunochemical Diagnostic Test (FIT) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Fecal Immunochemical Diagnostic Test (FIT) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Fecal Immunochemical Diagnostic Test (FIT) market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Fecal Immunochemical Diagnostic Test (FIT) Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, 2017-2031

5. Key Insights

• 5.1. Disease Prevalence & Incidence Rate globally with key countries
• 5.2. Regulatory Scenario
• 5.3. Pricing Analysis
• 5.4. COVID-19 Pandemic Impact on Industry

6. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, by Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Product Type, 2017-2031
  • 6.3.1. Kits & Reagents
  • 6.3.2. Analyzers
  • 6.3.3. Others
• 6.4. Market Attractiveness Analysis, by Product Type

7. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, by End-user

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by End-user, 2017-2031
  • 7.3.1. Hospitals & Diagnostic Laboratories
  • 7.3.2. Specialty Clinics
  • 7.3.3. Home Care Settings
  • 7.3.4. Research Institutes
• 7.4. Market Attractiveness Analysis, by End-user

8. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, by Region

• 8.1. Key Findings
• 8.2. Market Value Forecast, by Region
  • 8.2.1. North America
  • 8.2.2. Europe
  • 8.2.3. Asia Pacific
  • 8.2.4. Latin America
  • 8.2.5. Middle East & Africa
• 8.3. Market Attractiveness Analysis, by Region

9. North America Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast

• 9.1. Introduction
  • 9.1.1. Key Findings
• 9.2. Market Value Forecast, by Product Type, 2017-2031
  • 9.2.1. Kits & Reagents
  • 9.2.2. Analyzers
  • 9.2.3. Others
• 9.3. Market Value Forecast, by End-user, 2017-2031
  • 9.3.1. Hospitals & Diagnostic Laboratories
  • 9.3.2. Specialty Clinics
  • 9.3.3. Home Care Settings
  • 9.3.4. Research Institutes
• 9.4. Market Value Forecast, by Country, 2017-2031
  • 9.4.1. U.S.
  • 9.4.2. Canada
• 9.5. Market Attractiveness Analysis
  • 9.5.1. By Product Type
  • 9.5.2. By End-user
  • 9.5.3. By Country

10. Europe Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Product Type, 2017-2031
  • 10.2.1. Kits & Reagents
  • 10.2.2. Analyzers
  • 10.2.3. Others
• 10.3. Market Value Forecast, by End-user, 2017-2031
  • 10.3.1. Hospitals & Diagnostic Laboratories
  • 10.3.2. Specialty Clinics
  • 10.3.3. Home Care Settings
  • 10.3.4. Research Institutes
• 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 10.4.1. Germany
  • 10.4.2. U.K.
  • 10.4.3. France
  • 10.4.4. Italy
  • 10.4.5. Spain
  • 10.4.6. Rest of Europe
• 10.5. Market Attractiveness Analysis
  • 10.5.1. By Product Type
  • 10.5.2. By End-user
  • 10.5.3. By Country/Sub-region

11. Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product Type, 2017-2031
  • 11.2.1. Kits & Reagents
  • 11.2.2. Analyzers
  • 11.2.3. Others
• 11.3. Market Value Forecast, by End-user, 2017-2031
  • 11.3.1. Hospitals & Diagnostic Laboratories
  • 11.3.2. Specialty Clinics
  • 11.3.3. Home Care Settings
  • 11.3.4. Research Institutes
• 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 11.4.1. China
  • 11.4.2. Japan
  • 11.4.3. India
  • 11.4.4. Australia & New Zealand
  • 11.4.5. Rest of Asia Pacific
• 11.5. Market Attractiveness Analysis
  • 11.5.1. By Product Type
  • 11.5.2. By End-user
  • 11.5.3. By Country/Sub-region

12. Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product Type, 2017-2031
  • 12.2.1. Kits & Reagents
  • 12.2.2. Analyzers
  • 12.2.3. Others
• 12.3. Market Value Forecast, by End-user, 2017-2031
  • 12.3.1. Hospitals & Diagnostic Laboratories
  • 12.3.2. Specialty Clinics
  • 12.3.3. Home Care Settings
  • 12.3.4. Research Institutes
• 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 12.4.1. Brazil
  • 12.4.2. Mexico
  • 12.4.3. Rest of Latin America
• 12.5. Market Attractiveness Analysis
  • 12.5.1. By Product Type
  • 12.5.2. By End-user
  • 12.5.3. By Country/Sub-region

13. Middle East & Africa Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product Type, 2017-2031
  • 13.2.1. Kits & Reagents
  • 13.2.2. Analyzers
  • 13.2.3. Others
• 13.3. Market Value Forecast, by End-user, 2017-2031
  • 13.3.1. Hospitals & Diagnostic Laboratories
  • 13.3.2. Specialty Clinics
  • 13.3.3. Home Care Settings
  • 13.3.4. Research Institutes
• 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 13.4.1. GCC Countries
  • 13.4.2. South Africa
  • 13.4.3. Rest of Middle East & Africa
• 13.5. Market Attractiveness Analysis
  • 13.5.1. By Product Type
  • 13.5.2. By End-user
  • 13.5.3. By Country/Sub-region

14. Competition Landscape

• 14.1. Market Player - Competition Matrix (by tier and size of companies)
• 14.2. Market Share Analysis, by Company, 2022
• 14.3. Company Profiles
  • 14.3.1. Quest Diagnostics Incorporated
    • 14.3.1.1. Company Overview
    • 14.3.1.2. Product Portfolio
    • 14.3.1.3. SWOT Analysis
    • 14.3.1.4. Strategic Overview
  • 14.3.2. Sentinel CH. SpA
    • 14.3.2.1. Company Overview
    • 14.3.2.2. Product Portfolio
    • 14.3.2.3. SWOT Analysis
    • 14.3.2.4. Strategic Overview
  • 14.3.3. FUJIFILM Corporation
    • 14.3.3.1. Company Overview
    • 14.3.3.2. Product Portfolio
    • 14.3.3.3. SWOT Analysis
    • 14.3.3.4. Strategic Overview
  • 14.3.4. Quidel Corporation
    • 14.3.4.1. Company Overview
    • 14.3.4.2. Product Portfolio
    • 14.3.4.3. SWOT Analysis
    • 14.3.4.4. Strategic Overview
  • 14.3.5. Danaher (Beckman Coulter, Inc.)
    • 14.3.5.1. Company Overview
    • 14.3.5.2. Product Portfolio
    • 14.3.5.3. SWOT Analysis
    • 14.3.5.4. Strategic Overview
  • 14.3.6. Eiken Chemical Co., Ltd.
    • 14.3.6.1. Company Overview
    • 14.3.6.2. Product Portfolio
    • 14.3.6.3. SWOT Analysis
    • 14.3.6.4. Strategic Overview
  • 14.3.7. Freenome Holdings, Inc.
    • 14.3.7.1. Company Overview
    • 14.3.7.2. Product Portfolio
    • 14.3.7.3. SWOT Analysis
    • 14.3.7.4. Strategic Overview
  • 14.3.8. Immunostics, Inc.
    • 14.3.8.1. Company Overview
    • 14.3.8.2. Product Portfolio
    • 14.3.8.3. SWOT Analysis
    • 14.3.8.4. Strategic Overview
  • 14.3.9. BTNX, Inc.
    • 14.3.9.1. Company Overview
    • 14.3.9.2. Product Portfolio
    • 14.3.9.3. SWOT Analysis
    • 14.3.9.4. Strategic Overview
  • 14.3.10. Biohit Oyj
    • 14.3.10.1. Company Overview
    • 14.3.10.2. Product Portfolio
    • 14.3.10.3. SWOT Analysis
    • 14.3.10.4. Strategic Overview

관련자료